Nonmalignant Hematology

CCO&rsquo s expert faculty review and share their expert perspectives on key findings in nonmalignant hematologic disorders presented at the 2019 ASH annual meeting.

Share

Program Content

No activities added yet

Supporters

AstraZeneca

Celgene

Dova Pharmaceuticals

Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC

Karyopharm Therapeutics

Loxo Oncology subsidiary of Eli Lilly

Pharmacyclics an AbbVie Company